DE60204582D1 - Neue heteroaromatische amidderivate von 3beta aminoazabicyclooctanen, verfahren zu ihrer herstellung und ihre therapeutische verwendung - Google Patents

Neue heteroaromatische amidderivate von 3beta aminoazabicyclooctanen, verfahren zu ihrer herstellung und ihre therapeutische verwendung

Info

Publication number
DE60204582D1
DE60204582D1 DE60204582T DE60204582T DE60204582D1 DE 60204582 D1 DE60204582 D1 DE 60204582D1 DE 60204582 T DE60204582 T DE 60204582T DE 60204582 T DE60204582 T DE 60204582T DE 60204582 D1 DE60204582 D1 DE 60204582D1
Authority
DE
Germany
Prior art keywords
sub
pyridine
furo
thieno
group
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60204582T
Other languages
English (en)
Other versions
DE60204582T2 (de
Inventor
Thierry Imbert
Barbara Monse
Wouter Koek
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pierre Fabre Medicament SA
Original Assignee
Pierre Fabre Medicament SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pierre Fabre Medicament SA filed Critical Pierre Fabre Medicament SA
Publication of DE60204582D1 publication Critical patent/DE60204582D1/de
Application granted granted Critical
Publication of DE60204582T2 publication Critical patent/DE60204582T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Neurology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
DE60204582T 2001-11-02 2002-10-30 Neue heteroaromatische amidderivate von 3beta aminoazabicyclooctanen, verfahren zu ihrer herstellung und ihre therapeutische verwendung Expired - Lifetime DE60204582T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR0114220 2001-11-02
FR0114220A FR2831884B1 (fr) 2001-11-02 2001-11-02 Nouveaux derives amides heteroaromatiques de 3 beta-amino azabicyclooctane, leur procede de preparation et leurs applications en therapeutique
PCT/FR2002/003737 WO2003037904A1 (fr) 2001-11-02 2002-10-30 NOUVEAUX DERIVES AMIDES HETEROAROMATIQUES DE 3β-AMINO AZABICYCLOOCTANE, LEUR PROCEDE DE PREPARATION ET LEURS APPLICATIONS EN THERAPEUTIQUE

Publications (2)

Publication Number Publication Date
DE60204582D1 true DE60204582D1 (de) 2005-07-14
DE60204582T2 DE60204582T2 (de) 2006-03-16

Family

ID=8869022

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60204582T Expired - Lifetime DE60204582T2 (de) 2001-11-02 2002-10-30 Neue heteroaromatische amidderivate von 3beta aminoazabicyclooctanen, verfahren zu ihrer herstellung und ihre therapeutische verwendung

Country Status (9)

Country Link
US (1) US7456192B2 (de)
EP (1) EP1440075B1 (de)
AT (1) ATE297399T1 (de)
DE (1) DE60204582T2 (de)
DK (1) DK1440075T3 (de)
ES (1) ES2243779T3 (de)
FR (1) FR2831884B1 (de)
PT (1) PT1440075E (de)
WO (1) WO2003037904A1 (de)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU227684B1 (en) 2003-08-29 2011-11-28 Sanofi Aventis Adamantane and azabicyclo-octane and nonane derivatives and their use as dpp-iv inhibitors
EP2336125B1 (de) 2008-04-11 2013-01-09 Janssen Pharmaceutica N.V. Thiazolopyridin-2-yloxy-phenyl- und Thiazolopyrazin-2-yloxy-phenyl-amine als Modulatoren von Leukotrien-A4-hydrolase
EP2391628A4 (de) * 2009-01-28 2012-10-10 Astrazeneca Ab 2-azabicyclo[2.2.1]heptanverbindungen und anwendungen davon
US8193372B2 (en) * 2009-03-04 2012-06-05 Idenix Pharmaceuticals, Inc. Phosphothiophene and phosphothiazole HCV polymerase inhibitors
KR101727650B1 (ko) 2009-05-14 2017-04-17 얀센 파마슈티카 엔.브이. 류코트리엔 ａ4 하이드롤라아제의 조절제로서의 2개의 융합된 바이사이클릭 헤테로아릴 부분을 갖는 화합물
EP2935216B1 (de) 2012-12-17 2018-06-27 Sun Pharmaceutical Industries Limited Verfahren zur herstellung von tofacitinib und zwischenprodukten davon
CN109851551B (zh) * 2018-12-11 2022-05-20 大连金点生物科技有限公司 一种合成3-溴异烟酸中间体的方法
CA3133100A1 (en) 2019-03-19 2020-09-24 Boehringer Ingelheim Animal Health USA Inc. Anthelmintic aza-benzothiophene and aza-benzofuran compounds
JP2023528822A (ja) 2020-05-29 2023-07-06 ベーリンガー インゲルハイム アニマル ヘルス ユーエスエイ インコーポレイテッド 駆虫性複素環式化合物
WO2023073641A1 (en) 2021-11-01 2023-05-04 Boehringer Ingelheim Vetmedica Gmbh Anthelmintic pyrrolopyridazine compounds

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL59004A0 (en) 1978-12-30 1980-03-31 Beecham Group Ltd Substituted benzamides their preparation and pharmaceutical compositions containing them
FR2476088A2 (fr) 1979-01-16 1981-08-21 Delalande Sa Nouveaux derives du nor-tropane, leur procede de preparation et leur application en therapeutique
US4910193A (en) 1985-12-16 1990-03-20 Sandoz Ltd. Treatment of gastrointestinal disorders
AU3364493A (en) 1992-01-28 1993-09-01 Smithkline Beecham Plc Compounds as calcium channel antagonists
FR2738569B1 (fr) * 1995-09-12 1997-11-28 Pf Medicament Nouveaux derives naphtamide de 3 beta-amino azabicyclo octane ou nonane, leur procede de preparation, leur utilisation a titre de medicament antipsychotique
SE9902987D0 (sv) 1999-08-24 1999-08-24 Astra Pharma Prod Novel compounds

Also Published As

Publication number Publication date
FR2831884A1 (fr) 2003-05-09
EP1440075A1 (de) 2004-07-28
FR2831884B1 (fr) 2003-12-26
US7456192B2 (en) 2008-11-25
US20050080085A1 (en) 2005-04-14
DK1440075T3 (da) 2005-08-22
EP1440075B1 (de) 2005-06-08
ATE297399T1 (de) 2005-06-15
DE60204582T2 (de) 2006-03-16
ES2243779T3 (es) 2005-12-01
PT1440075E (pt) 2005-10-31
WO2003037904A1 (fr) 2003-05-08

Similar Documents

Publication Publication Date Title
DE60130562D1 (de) Azaindolderivate, verfahren zu ihrer herstellung und ihre verwendung als antitumormittel
HRP20070328T3 (en) SUBSTITUTED 8'-PYRI(MI)DINYL-DIHYDROSPIRO-[CYCLOALKLYMINE]-PYRIMIDO[1,2a]PYRIMIDIN-6-ONE DERIVATIVES
DE60204582D1 (de) Neue heteroaromatische amidderivate von 3beta aminoazabicyclooctanen, verfahren zu ihrer herstellung und ihre therapeutische verwendung
ATE226208T1 (de) 4-oxo-4,7-dihydro-thieno(2,3-b)pyridin-5- carboxamide als antivirale mittel
DE60217062D1 (de) Verfahren zur herstellung von clopidogrel
IL165503A0 (en) Method for preparing fused oxazinones from ortho-amino aromatic carboxylic acid and a carboxylic acid in the presence of a sulfonyl chloride and pyridine
PE20030431A1 (es) DERIVADOS QUINUCLIDINAS COMO AGONISTAS DEL RECEPTOR NICOTINICO DE LA ACETILCOLINA TIPO a7
WO2006098961A3 (en) Fused thieno [2, 3-b] pyridine and thiazolo [5, 4-b] pyridine compounds for inhibiting ksp kinesin activity
EP1802634A2 (de) Thiophene und ihre verwendung als antitumormittel
NO20022185D0 (no) Bisykliske og trisykliske heteroaromatiske forbindelser
EP1167367A4 (de) Thienopyrimidin-verbindungen und verfahren zu ihrer herstellung
NZ336302A (en) Quinoline and quinazoline compounds useful in therapy, particularly in the treatment of benign prostatic hyperplasia
WO2007010138A3 (fr) Derives de ν-(arylalkyl)-1h-pyrrolopyridine-2-carboxamides, leur preparation et leur application en therapeutique
EA200300151A1 (ru) ПРОИЗВОДНЫЕ 2-ПИРИДИНИЛ-6,7,8,9-ТЕТРАГИДРОПИРИМИДО[1,2-a]ПИРИМИДИН-4-ОНА И 7-ПИРИДИНИЛ-2,3-ДИГИДРОИМИДАЗО[1,2-a]ПИРИМИДИН-5(1H)ОНА
ATE261445T1 (de) Neue 1,8-naphtyridin-2(1h)-on-derivate
DE69329231D1 (de) Pyrazolo(4,3-c)pyridine, ein Verfahren zu ihrer Herstellung und ihre Verwendung als Inhibitoren der Serotonin-Wiederaufnahme
WO2008107543A3 (fr) Derives de pyrrolopyridine-2-carboxamides, leur preparation et leur application en therapeutique
EA201070217A1 (ru) Производные трициклических n-гетероарилкарбоксамидов, их получение и их применение в терапии
MA19817A1 (fr) Nouveaux derives du thioformamide et leur preparation .
EP1496059A4 (de) Kondensierte bicyclische pyrimidinderivate
NO20073165L (no) Fremgangsmate for fremstillingen av N-demetylolanzapin
EA200500572A1 (ru) Новые соединения пирроло[3,4-c]карбазола и пиридо[2,3-b]пирроло[3,4-e]индола, способ их получения и фармацевтические композиции, которые их содержат
KR950032205A (ko) 5,6-디 히드로-4H-티에노 [3,4-c] 피롤유도체, 그것의 제조방법 및 치료에의 이용
PL327873A1 (en) Novel bis-pyrido [4,3-b] carbazolic compounds, method of obtaining such compounds and pharmaceutic compositions containing them
ATE216387T1 (de) 5,10-dihydrodipyrido(2,3-b: 2,3-e)pyridazin und 5,10-dihydro(2,3-b:3,2-e)pyrazin, verfahren zu ihrer herstellung und diese enhaltende pharmazeutische zubereitungen

Legal Events

Date Code Title Description
8364 No opposition during term of opposition